Standard Lithium Ltd vs Tilray Brands Inc — how do they compare? Standard Lithium Ltd trades at $1.61 (market cap $398.07M), while Tilray Brands Inc trades at $3.6 (market cap $530.54M). The key difference: Tilray Brands Inc is the larger of the two by market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 1,564,155). Which is the better fit depends on your goals — on Pluang, investors hold Standard Lithium Ltd for 23 Days and Tilray Brands Inc for 31 Days on average.
| SLI | TLRY | |
|---|---|---|
Market Cap | $398.07M | $530.54M |
Volume | 1,564,155 | 9,099,075 |
Sector | Basic Materials | Health |
52-Week High | $5.65 | $21.00 |
52-Week Low | $1.61 | $3.57 |
Typical Hold Time | 23 Days | 31 Days |
Enterprise Value | $260.98M | $684.46M |
Signals from Pluang's Aura AI — not financial advice
Standard Lithium (SLI) trades at $1.65, down 4.62% today, with a bearish technical signal despite bullish oscillators. The company shows negative profitability with ROE of -15.55% and ROA of -14.17%, though recent quarterly EPS beat expectations. Positive developments include progress toward a 2026 final investment decision for the Arkansas lithium project and expanded offtake agreements. Cash flow remains supported by financing activities despite negative operational cash flow.
The investment case hinges on successful project execution and lithium market dynamics. Analysts are unanimously bullish with a $3.83 price target, representing significant upside. Key risks include execution delays, negative cash flow, and commodity price volatility. The stock offers high-risk, high-reward exposure to North American lithium production growth.
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →